462 related articles for article (PubMed ID: 28985607)
21. Self-Assembled Monomethoxy (Polyethylene Glycol)-b-P(D,L-Lactic-co-Glycolic Acid)-b-P(L-Glutamic Acid) Hybrid-Core Nanoparticles for Intracellular pH-Triggered Release of Doxorubicin.
Xu H; Cai C; Gou J; Sui B; Jin J; Xu H; Zhang Y; Wang L; Zhai Y; Tang X
J Biomed Nanotechnol; 2015 Aug; 11(8):1354-69. PubMed ID: 26295138
[TBL] [Abstract][Full Text] [Related]
22. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
23. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride.
Du Y; Chen W; Zheng M; Meng F; Zhong Z
Biomaterials; 2012 Oct; 33(29):7291-9. PubMed ID: 22795540
[TBL] [Abstract][Full Text] [Related]
24. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.
Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J
Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356
[TBL] [Abstract][Full Text] [Related]
25. Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells.
Zayed GM; Kamal I; Abdelhafez WA; M Alsharif F; Amin MA; Shaykoon MSA; Sarhan HA; Abdelsalam AM
Pharm Res; 2018 Mar; 35(6):112. PubMed ID: 29603025
[TBL] [Abstract][Full Text] [Related]
26. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy.
Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X
Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147
[TBL] [Abstract][Full Text] [Related]
27. IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy.
Fu X; Wang X; Zhou S; Zhang Y
Int J Nanomedicine; 2017; 12():3751-3766. PubMed ID: 28553112
[TBL] [Abstract][Full Text] [Related]
28. Zwitterionic shielded polymeric prodrug with folate-targeting and pH responsiveness for drug delivery.
Li L; Song Y; He J; Zhang M; Liu J; Ni P
J Mater Chem B; 2019 Feb; 7(5):786-795. PubMed ID: 32254853
[TBL] [Abstract][Full Text] [Related]
29. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
Tam YT; To KK; Chow AH
Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
[TBL] [Abstract][Full Text] [Related]
30. Diselenide linkage containing triblock copolymer nanoparticles based on Bi(methoxyl poly(ethylene glycol))-poly(ε-carprolactone): Selective intracellular drug delivery in cancer cells.
Hailemeskel BZ; Hsu WH; Addisu KD; Andrgie AT; Chou HY; Lai JY; Tsai HC
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109803. PubMed ID: 31349440
[TBL] [Abstract][Full Text] [Related]
31. Dynamic in vivo imaging of dual-triggered microspheres for sustained release applications: synthesis, characterization and cytotoxicity study.
Efthimiadou EK; Tapeinos C; Chatzipavlidis A; Boukos N; Fragogeorgi E; Palamaris L; Loudos G; Kordas G
Int J Pharm; 2014 Jan; 461(1-2):54-63. PubMed ID: 24286923
[TBL] [Abstract][Full Text] [Related]
32. Amphiphilic Diblock Terpolymer PMAgala-b-P(MAA-co-MAChol)s with Attached Galactose and Cholesterol Grafts and Their Intracellular pH-Responsive Doxorubicin Delivery.
Wang Z; Luo T; Sheng R; Li H; Sun J; Cao A
Biomacromolecules; 2016 Jan; 17(1):98-110. PubMed ID: 26682643
[TBL] [Abstract][Full Text] [Related]
33. A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery.
Hou J; Guo C; Shi Y; Liu E; Dong W; Yu B; Liu S; Gong J
Int J Pharm; 2017 Nov; 533(1):73-83. PubMed ID: 28943209
[TBL] [Abstract][Full Text] [Related]
34. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
[TBL] [Abstract][Full Text] [Related]
35. Galactose-Containing Polymer-DOX Conjugates for Targeting Drug Delivery.
Sun Y; Zhang J; Han J; Tian B; Shi Y; Ding Y; Wang L; Han J
AAPS PharmSciTech; 2017 Apr; 18(3):749-758. PubMed ID: 27287244
[TBL] [Abstract][Full Text] [Related]
36. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
37. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
Kashyap S; Singh N; Surnar B; Jayakannan M
Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
[TBL] [Abstract][Full Text] [Related]
38. Balancing the stability and drug release of polymer micelles by the coordination of dual-sensitive cleavable bonds in cross-linked core.
Deng H; Zhang Y; Wang X; Jianhuazhang ; Cao Y; Liu J; Liu J; Deng L; Dong A
Acta Biomater; 2015 Jan; 11():126-36. PubMed ID: 25288518
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
40. Fullerene (C60)-based tumor-targeting nanoparticles with "off-on" state for enhanced treatment of cancer.
Shi J; Wang B; Wang L; Lu T; Fu Y; Zhang H; Zhang Z
J Control Release; 2016 Aug; 235():245-258. PubMed ID: 27276066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]